- Capital Cube•18 hours agoTaro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016
Click here to see latest analysisTaro Pharmaceutical Industries Ltd. reports financial results for the year ended March 31, 2016.We analyze the earnings along side the following peers of Taro Pharmaceutical Industries Ltd. – Johnson & Johnson and Novartis AG Sponsored ADR (JNJ-US and NVS-US) that have also reported for this period.HighlightsGross margins widened from 78.40% […] (Read more...) The post Taro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 appeared first on CapitalCube.
- Capital Cube•7 days ago
Click here to see latest analysisCapitalcube gives Taro Pharmaceutical Industries Ltd. a score of 88.Our analysis is based on comparing Taro Pharmaceutical Industries Ltd. with the following peers – Mylan N.V., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Johnson & Johnson, Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Teligent, […] (Read more...) The post Taro Pharmaceutical Industries Ltd. – Value Analysis (NYSE:TARO) : July 20, 2016 appeared first on CapitalCube.
Taro Pharmaceutical Industries Ltd.NYSE
After hours: 138.230.00 (0.00%) as of 4:32 PM EDT
|Bid||136.00 x 100|
|Ask||155.00 x 100|
|52wk Range||122.99 - 157.99|
|Day's Range||135.17 - 146.11|
|Avg Vol (3m)||295,014|
As of 4:02 PM EDT. Market closed.